MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Clinical features"

  • 2017 International Congress

    Myoclonus in the Elderly: Retrospective Analysis of Clinical and Electrophysiological characteristics of patients referred to an electrophysiology laboratory

    M. Kiziltan, A. Gunduz, M. Tutuncu, U. Uygunoglu, A. Sifoglu, S. Ertan, H. Apaydin, M. Bozluolcay, S. Saip, G. Kiziltan (Istanbul, Turkey)

    Objective: In this report, we aimed to investigate clinical and electrophysiological features of patients with late-onset myoclonus. Background: Myoclonus is characterized by sudden, brief and…
  • 2017 International Congress

    Cefepime-induced encephalopathy and myoclonus

    T. Rasameesoraj, X.x. Yu, A. Ahmed, H. Fernandez (Cleveland, OH, USA)

    Objective: To raise awareness of cephalosporin-induced encephalopathy and myoclonus. Background: Myoclonus occurs in 15% of antibiotic-associated encephalopathy, especially with penicillins and cephalosporins. Cefepime and ceftazidime…
  • 2017 International Congress

    Axial Myoclonus in a Patient with PSP

    R. Passo, T. Clark (Portland, OR, USA)

    Objective: This is a case report from the Portland VA Medical Center. Background: PSP is a parkinsonian neurodegenerative disorder characterized by deposition of tau in…
  • 2017 International Congress

    Asymmetric Orthostaic Myoclonus – A Case Series

    Y.-c. Tai, J.-c. Tsou, S.-P. Hsu (Kaohsiung City, Taiwan)

    Objective: To present the first case series of asymmetric orthostatic myoclnus and its reversibility along with the improvement of the underlying disease Background: Orthostatic myoclonus…
  • 2017 International Congress

    Reappraisal of Progressive Myoclonus Ataxia

    S. vd Veen, R. Zutt, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: To define the clinical, electrophysiological and etiological features of progressive myoclonus ataxia (PMA). Background: PMA, formerly known as the Ramsay Hunt syndrome, is a…
  • 2017 International Congress

    Clinical and electrophysiological features of seven patients with moving toes syndrome: Is it a type of spinal segmental myoclonus?

    G. Kiziltan, H. Kurucu, C. Yalcinkaya, A. Gunduz, M. E. Kiziltan (Istanbul, Turkey)

    Objective: We aimed to present a case series of moving toes syndrome to show how clinical presentation and electrophysiological findings may change. Background: The moving…
  • 2017 International Congress

    Gait impairment and cognitive changes in a case of thalamic dementia and motor neuron disease.

    S. O'Shea, O. Levy, J.P. Vonsattel, E. Cortes, K. Marder, H. Mitsumoto, R. Alcalay (New York, NY, USA)

    Objective: To describe a case of a 54-year-old woman diagnosed with atypical corticobasal syndrome (CBS). Neuropathological studies revealed that she had thalamic dementia with motor…
  • 2016 International Congress

    Myoclonus complicating chickenpox: A case report

    F. Imounan, N. Daoudi (Meknes, Morocco)

    Objective: To report myoclonus and other movements disorders complicating chickenpox. Background: The meningoencephalitis is a rare complication of chickenpox. The occurrence of movements disorders is…
  • 2016 International Congress

    Alcohol-responsive action myoclonus of the leg in prostate cancer: A novel paraneoplastic syndrome

    P. Termsarasab, S.J. Frucht (New York, NY, USA)

    Objective: To describe two patients with prostate cancer and identical phenotypes of likely paraneoplastic unilateral leg myoclonus. Background: Paraneoplastic movement disorders (PMDs) in prostate cancer…
  • 2016 International Congress

    How do we clinically distinguish subtypes of myoclonus? A retrospective study

    R. Zutt, J.W. Elting, H. van der Hoeven, F. Lange, M.A.J. Tijssen (Groningen, Netherlands)

    Objective: To evaluate the accuracy of clinical phenotyping in a heterogeneous cohort of patients presenting with myoclonus and to determine clinical characteristics. Furthermore, we studied…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley